Atlas Trials

Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A

Clinical trial NCT01811875 · TERMINATED

Trial details

NCT number
NCT01811875
Sponsor
Bio Products Laboratory
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Haemophilia A
Start date
2014-11-21
Primary completion
2017-08-31
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.